If Canada ordered 500,000 smallpox vaccinations weeks before the monkeypox outbreak, this isn't necessarily proof that this was planned, as it seems to imply.
Everything is relative. Is it standard procedure for Canada to stockpile vaccines? Has Canada regularly ordered vaccines in the past, even for "eradicated" diseases and, if so, at what interval?
If this vaccine order is out-of-the-ordinary, I'd be suspicious. Articles like this need to research how out-of-the-ordinary this is rather than just say that it happened.
Fyi: "COPENHAGEN, Denmark, November 12, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that Health Canada has expanded the approval of the Company’s non-replicating smallpox vaccine, IMVAMUNE® to include additional indications – specifically, monkeypox and related orthopoxvirus infections and disease in adults 18 years of age and older determined to be at high risk for exposure.
The extended approval was granted following assessment of additional clinical and non-clinical data, generated since IMVAMUNE received approval as a smallpox vaccine by Health Canada in 2013. These data include among others a Phase 3 study which demonstrated that, in terms of efficacy, IMVAMUNE was non-inferior to replicating smallpox vaccines, while also confirming its favorable benefit/risk profile. IMVAMUNE is approved in Canada under the Extraordinary Use New Drugs (EUNDS) Pathway."
If Canada ordered 500,000 smallpox vaccinations weeks before the monkeypox outbreak, this isn't necessarily proof that this was planned, as it seems to imply.
Everything is relative. Is it standard procedure for Canada to stockpile vaccines? Has Canada regularly ordered vaccines in the past, even for "eradicated" diseases and, if so, at what interval?
If this vaccine order is out-of-the-ordinary, I'd be suspicious. Articles like this need to research how out-of-the-ordinary this is rather than just say that it happened.
Fyi: "COPENHAGEN, Denmark, November 12, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that Health Canada has expanded the approval of the Company’s non-replicating smallpox vaccine, IMVAMUNE® to include additional indications – specifically, monkeypox and related orthopoxvirus infections and disease in adults 18 years of age and older determined to be at high risk for exposure.
The extended approval was granted following assessment of additional clinical and non-clinical data, generated since IMVAMUNE received approval as a smallpox vaccine by Health Canada in 2013. These data include among others a Phase 3 study which demonstrated that, in terms of efficacy, IMVAMUNE was non-inferior to replicating smallpox vaccines, while also confirming its favorable benefit/risk profile. IMVAMUNE is approved in Canada under the Extraordinary Use New Drugs (EUNDS) Pathway."
https://www.bavarian-nordic.com/investor/news/news.aspx?news=6132
Interesting that this particular vax is approved under " extraordinary use" despite it being used since '13, as i understand.